Infectious Diseases Symposium 

sponsored by FWMEP and Parkview Hospital

AGENDA
11:45A-12:25P  Registration/Lunch/Vendors
12:25-12:30P     Welcome/Introduction
12:30-1:15P       Tuberculosis Diagnoses and Management 
                            Sarah Burkholder,BSN - Indiana State Department of Health
1:15 - 2:05P       A 21st Century Renaissance or Simple Mirage: New Antibiotics in 2014-2015 
                             Trent Towne, PharmD - Manchester University College of Pharmacy
2:05-2:45P         Rapid Molecular Diagnostics 
                              Ann Vick -  Lab Scientist &  Karen Irven - Lab Lead Scientist - Parkview
2:45-3:05P         BREAK - visit your vendors
3:05 -3:40P        New Therapies for Hepatitis C  -Travis Hays, MD - Infectious Diseases - Parkview
3:40 - 4:15:        Sepsis - What is it, Why should you care? 
                               Susan McAlister, RN - Director, Enterprise Care Mgmt - Parkview 
                               Jackie Myers, RN - Director, Nursing Services - Parkview
4:15 - 5P            Bacteria for Which No Antibiotics Exist 
                               Scott Stienecker, MD - Medical Director of Epidemiology & Infection Prevention-                                   Parkview
Objectives:
1.  Describe symptoms and etiology of tuberculosis
2.  Describe treatment of tuberculosis
3.  Identify key pharmacokinetic/pharmacodynamic principles for newer gram-positive antibiotics, including the impact on drug dosing
4.  Compare and contrast novel beta-lactam/beta-lactamase inhibitor combinations with respect to spectrum of activity
5.  Identify new rapid molecular diagnostic testing that could be incorporated into your practice
6.  Desribe the benefit of molecular diagnostic testing vs standard microbiology techniques
7.  Discuss the new therapies available for patients diagnosed with Hepatitis C
8.  Identify when those new therapies would benefit the patient with Hepatitis C
9.  Describe sepsis and the sepsis campaign
10. Identify initiatives that are helpful in dealing with patients with sepsis
11. Define CRE, ESBL and KPC
12. Identify three managment options for CRE or KPC bacteria

 Continuing Eduation Credits:
- The Fort Wayne Medical Education Program is accredited by the Indiana State Medical
Association to provide continuing medical education for physicians.
- The Fort Wayne Medical Education Program designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.